Dalbavancin in catheter-related bloodstream infections: a pilot study.
Le infezioni in medicina(2023)
摘要
Our results indicate that single-dose dalbavancin is highly effective, well-tolerated, and cost-saving for Gram-positive CRBSI.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要